To Evaluate the Efficacy and Safety of Tislelizumab in Combination With Lenvatinib in Patients With Selected Solid Tumors

⟵ Back to Search Results

Beigene Study ID

BGB-A317-212

ClinicalTrials.gov ID

NCT05014828

Sex: All

Age: 18 Years and older (Adult, Older Adult)

No Study Documents

Locations

Sex: All

Age: 18 Years and older (Adult, Older Adult)

No Study Documents